# Effect of Vorinostat on ACTH Producing Pituitary Adenomas in Cushing s Disease

> **NCT04339751** · PHASE2 · WITHDRAWN · sponsor: **National Institute of Neurological Disorders and Stroke (NINDS)**

## Conditions studied

- Cushing's Disease

## Interventions

- **DRUG:** Vorinostat

## Key facts

- **NCT ID:** NCT04339751
- **Lead sponsor:** National Institute of Neurological Disorders and Stroke (NINDS)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2025-04-11
- **Primary completion:** 2025-04-11
- **Final completion:** 2025-04-11
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Lack of enrollment.
- **Last updated:** 2025-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04339751

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04339751, "Effect of Vorinostat on ACTH Producing Pituitary Adenomas in Cushing s Disease". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04339751. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*